• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Financial Services·BIOGEN.BO
Share

Biogen Pharmachem Industries Limited Stocks

₹ 0.25Last Updated 29.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

₹ 2.66M

₹ 0.25
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

02.09.2025 16:10

SMA drugmaker Scholar Rock may jump on upcoming FDA decision, Freedom Broker thinks

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Biogen Pharmachem Industries Ltd. began its operations on July 13, 1995, from its headquarters in Rajkot, India. The company's main business activity focuses on dealing in and trading various shares and securities.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.10.2026 22:43

Intel could lose $140 billion in market capitalization. Its stock is heading for its worst day ever.

30.10.2026 22:00

"Buy Rough Diamonds": Big Tech Bonds Have Become More Attractive Than Stocks — BofA

30.10.2026 21:05

From AI Experiments to Implementation: Why Does JPMorgan Expect Palantir's Stock to Rise 33%?

30.10.2026 20:37

The cost of insurance against defaults by tech giants has hit a new all-time high

30.10.2026 20:07

"Value Isn't Created by Expectations": Analysts Advise Buying Amazon Stock on a Pullback

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026